Wesley Chan1, Alexis M Flowers2, Benjamin I Meyer3, Beau B Bruce4, Nancy J Newman5, Valérie Biousse6. 1. Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Road NE, Suite B4500, Atlanta, GA 30322, United States. Electronic address: wesley.chan@emory.edu. 2. Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Road NE, Suite B4500, Atlanta, GA 30322, United States. Electronic address: alexis.m.flowers@emory.edu. 3. Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Road NE, Suite B4500, Atlanta, GA 30322, United States. 4. Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Road NE, Suite B4500, Atlanta, GA 30322, United States; Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, United States; Department of Epidemiology, Emory University School of Medicine, Atlanta, GA 30322, United States. Electronic address: bbbruce@emory.edu. 5. Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Road NE, Suite B4500, Atlanta, GA 30322, United States; Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, United States; Department of Neurological Surgery, Emory University School of Medicine, Atlanta, GA 30322, United States. Electronic address: ophtnjn@emory.edu. 6. Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Road NE, Suite B4500, Atlanta, GA 30322, United States; Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, United States. Electronic address: vbiouss@emory.edu.
Abstract
OBJECTIVE: Acute central retinal artery occlusion (CRAO) is an emergency with poor visual outcome. Intravenous thrombolysis within 4.5 h of vision loss is safe and may improve vision, but is rarely administered because of frequent delays in presentation. We describe a subgroup of CRAO patients presenting within 24 h of vision loss to a tertiary care center affiliated with a comprehensive stroke center. MATERIALS AND METHODS: Retrospective review of 181 consecutive CRAO patients seen at our institution from 2010 to 2020. RESULTS: Out of 181 CRAO patients, 62 (34%) presented within 24 h of vision loss and tended to live closer to the hospital. These patients were more likely to be admitted to the hospital and receive comprehensive stroke work-up compared to patients who presented after 24 h of vision loss. Patients presenting after 24 h did not necessarily receive prior appropriate work-up at outside institutions. Conservative treatments for CRAO were administered to 20/181 patients, and only 3 patients received intravenous thrombolysis. CONCLUSIONS: Patients with CRAO do not present to the emergency department fast enough and diagnosis of CRAO is often delayed. Despite having a protocol in place, only 3/181 patients received IV thrombolysis, emphasizing the difficulty in administering very acute treatments for CRAO. Public education regarding CRAO is necessary to improve presentation times, management, and visual outcomes. Hospitals need to develop accelerated diagnostic pathway protocols for patients with acute vision loss so that CRAO patients may be diagnosed and be considered for potential acute treatments as quickly as possible.
OBJECTIVE: Acute central retinal artery occlusion (CRAO) is an emergency with poor visual outcome. Intravenous thrombolysis within 4.5 h of vision loss is safe and may improve vision, but is rarely administered because of frequent delays in presentation. We describe a subgroup of CRAO patients presenting within 24 h of vision loss to a tertiary care center affiliated with a comprehensive stroke center. MATERIALS AND METHODS: Retrospective review of 181 consecutive CRAO patients seen at our institution from 2010 to 2020. RESULTS: Out of 181 CRAO patients, 62 (34%) presented within 24 h of vision loss and tended to live closer to the hospital. These patients were more likely to be admitted to the hospital and receive comprehensive stroke work-up compared to patients who presented after 24 h of vision loss. Patients presenting after 24 h did not necessarily receive prior appropriate work-up at outside institutions. Conservative treatments for CRAO were administered to 20/181 patients, and only 3 patients received intravenous thrombolysis. CONCLUSIONS: Patients with CRAO do not present to the emergency department fast enough and diagnosis of CRAO is often delayed. Despite having a protocol in place, only 3/181 patients received IV thrombolysis, emphasizing the difficulty in administering very acute treatments for CRAO. Public education regarding CRAO is necessary to improve presentation times, management, and visual outcomes. Hospitals need to develop accelerated diagnostic pathway protocols for patients with acute vision loss so that CRAO patients may be diagnosed and be considered for potential acute treatments as quickly as possible.
Authors: Christina J Flaxel; Ron A Adelman; Steven T Bailey; Amani Fawzi; Jennifer I Lim; G Atma Vemulakonda; Gui-Shuang Ying Journal: Ophthalmology Date: 2019-09-25 Impact factor: 12.079
Authors: Katriel E Lee; Christine Tschoe; Stephanie A Coffman; Carol Kittel; Patrick A Brown; Quang Vu; Kyle M Fargen; Bartlett H Hayes; Stacey Q Wolfe Journal: J Stroke Cerebrovasc Dis Date: 2020-12-10 Impact factor: 2.136
Authors: Dan Milea; Raymond P Najjar; Jiang Zhubo; Daniel Ting; Caroline Vasseneix; Xinxing Xu; Masoud Aghsaei Fard; Pedro Fonseca; Kavin Vanikieti; Wolf A Lagrèze; Chiara La Morgia; Carol Y Cheung; Steffen Hamann; Christophe Chiquet; Nicolae Sanda; Hui Yang; Luis J Mejico; Marie-Bénédicte Rougier; Richard Kho; Tran Thi Ha Chau; Shweta Singhal; Philippe Gohier; Catherine Clermont-Vignal; Ching-Yu Cheng; Jost B Jonas; Patrick Yu-Wai-Man; Clare L Fraser; John J Chen; Selvakumar Ambika; Neil R Miller; Yong Liu; Nancy J Newman; Tien Y Wong; Valérie Biousse Journal: N Engl J Med Date: 2020-04-14 Impact factor: 91.245
Authors: Johanna Helenius; E Murat Arsava; Joshua N Goldstein; Dean M Cestari; Ferdinando S Buonanno; Bruce R Rosen; Hakan Ay Journal: Ann Neurol Date: 2012-08 Impact factor: 10.422
Authors: Tahreem A Mir; Ahmad Z Arham; Wei Fang; Fahad Alqahtani; Mohamad Alkhouli; Julia Gallo; David M Hinkle Journal: Am J Ophthalmol Date: 2019-01-26 Impact factor: 5.258
Authors: Gautam Vangipuram; Louise Yang; M Parker Weigle; Barton L Blackorby; Kevin J Blinder; Sabin Dang; Gaurav K Shah Journal: Graefes Arch Clin Exp Ophthalmol Date: 2021-03-12 Impact factor: 3.117
Authors: Brian Mac Grory; Sean R Landman; Paul D Ziegler; Chantal J Boisvert; Shane P Flood; Christoph Stretz; Tracy E Madsen; Michael E Reznik; Shawna Cutting; Elizabeth E Moore; Hunter Hewitt; James B Closser; Jose Torres; Patrick J Lavin; Karen L Furie; Ying Xian; Wayne Feng; Valérie Biousse; Matthew Schrag; Shadi Yaghi Journal: Stroke Date: 2021-06-07 Impact factor: 7.914
Authors: Luca Rosignoli; Edward R Chu; John E Carter; Daniel A Johnson; Jeong-Hyeon Sohn; Sepehr Bahadorani Journal: Korean J Ophthalmol Date: 2021-11-08
Authors: Carolin Hoyer; Simon Winzer; Volker Puetz; Kristina Szabo; Egbert Matthé; Ida Heinle; Vesile Sandikci; Darius Nabavi; Michael Platten Journal: Neurol Res Pract Date: 2022-08-01
Authors: Daniel A Wenzel; Sven Poli; Maria Casagrande; Vasyl Druchkiv; Martin S Spitzer; Karl Ulrich Bartz-Schmidt; Carsten Grohmann; Maximilian Schultheiss Journal: Front Med (Lausanne) Date: 2022-07-06